Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis causes cerebral dysfunction in the short and long term and induces disruption of the blood-brain barrier (BBB), neuroinflammation, hypoperfusion, and accumulation of amyloid beta (A beta) and tau protein in the brain. White matter changes and brain atrophy can be detected using brain imaging, but unfortunately, there is no specific treatment that directly addresses the underlying mechanisms of cognitive impairments in sepsis. Here, we review the underlying mechanisms of sepsis-associated brain injury, with a focus on BBB dysfunction and A beta and tau protein accumulation in the brain. We also describe the neurological manifestations and imaging findings of sepsis-associated brain injury, and finally, we propose potential therapeutic strategies for acute and long-term cognitive impairments associated with sepsis. In the acute phase of sepsis, we suggest using antibiotics (such as rifampicin), targeting proinflammatory cytokines, and preventing ischemic injuries and hypoperfusion. In the late phase of sepsis, we suggest targeting neuroinflammation, BBB dysfunction, A beta and tau protein phosphorylation, glycogen synthase kinase-3 beta (GSK3 beta), and the receptor for advanced glycation end products (RAGE). These proposed strategies are meant to bring new mechanism-based directions for future basic and clinical research aimed at preventing or ameliorating acute and long-term cognitive impairments in patients with sepsis.

Automated summary

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It induces cerebral dysfunction, disruption of the blood-brain barrier, neuroinflammation, hypoperfusion, and accumulation of amyloid beta and tau protein in the brain. However, there is currently no specific treatment for cognitive impairments in sepsis. Antibiotics, targeting proinflammatory cytokines, and preventing ischemic injuries and hypoperfusion are suggested for the acute phase, while targeting neuroinflammation, blood-brain barrier dysfunction, protein phosphorylation, and specific receptors are suggested for the late phase of sepsis.